Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications: supplementary materials

These are peer-reviewed supplementary materials for the article 'Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications' published in the Journal of Comparative Effectiveness Research.Previous knowledge about malariaInformation about malariaConference about context understandingOpinion researchClinical dataExclusive to interviewerAim: Malaria is an infection caused by protozoa of genus Plasmodium, considered the one associated with increasingly large outbreaks. Methods: A cross-sectional study was conducted with residents in the northern region of Brazil on the willingness to pay (WTP) for a hypothetical vaccine against malaria (effective protection of 80%). Results: Of 616 people interviewed, most interviewees were female (61%) and were employed (97%). The median individual maximum WTP for a hypothetical malaria vaccine was US$11.90 (BRL 50). Conclusion: The northern region of Brazil is one of the largest markets for a malaria vaccine due to its epidemiological relevance. Consequently, economic studies will be important to assist in the assessment of the potential price and value of new vaccines.

本数据集为发表于《比较有效性研究杂志》之文章《巴西对于假设性疟疾疫苗的支付意愿：一项横断面研究和其意义》的同行评审补充材料。其中包含了关于疟疾的先验知识、疟疾信息、语境理解会议资料、意见调查以及临床数据。数据仅限于受访者。研究目的：疟疾是由疟原虫属（Plasmodium）引起的感染，与日益增多的爆发性疫情相关。研究方法：对巴西北部地区的居民进行了横断面调查，以了解他们对假设性疟疾疫苗（有效保护率为80%）的支付意愿（WTP）。研究结果：在616名受访者中，大多数为女性（61%）且为在职人员（97%）。假设性疟疾疫苗的个人最高支付意愿中位数约为11.90美元（巴西雷亚尔50）。研究结论：巴西北部地区由于其流行病学的重要性，是疟疾疫苗的最大市场之一。因此，经济研究将对于评估新疫苗的潜在价格和价值具有重要意义。